Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D. Anker, Milton Packer, Vijay Chopra et al.|New England Journal of Medicine|2021Cited by 4.6k
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trialJaved Butler, Milton Packer, Stefan D. Anker et al.|European Heart Journal|2020Cited by 179
Baseline Characteristics of Patients with Heart Failure with Preserved Ejection Fraction in the EMPEROR-Preserved TrialStefan D. Anker, Milton Packer, Javed Butler et al.|European Journal of Heart Failure|2020Cited by 135
Clostridium Difficile ColitisMarylise Boutros, Jeffrey Barkun, Maha Al-Shaibi et al.|Transplantation|2012Cited by 122